Meta Pixel

News and Announcements

OpenDNA Uses AI to Enable Businesses to Better Understand Their Users

  • Published January 30, 2018 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Please click the video below to see what it is the OpenDNA do…

People are special – down to the individual. Individuals look for respect and recognition in their conjoined off and online experiences. They have learned to ignore broadcasted content in favor of critical selection of what they engage in.

The generic promotion of your business is no longer loud enough to cut through the saturation. It’s time to relook at the way you talk to the customer and it starts with listening.

OpenDNA is an AI company that enables businesses to better understand their individual users. We build psychographic, personality & behavioral maps of users; giving them the most personalized, relevant and targeted experiences. Our technology has proven to improve user engagement, retention and revenue.

 

Request Information

Capital Insights
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be  Attracting Big Pharma’s Attention

Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Join over 45,000+ sophisticated investors

Join Now